Trials / Completed
CompletedNCT00134472
Therapeutic Hypothermia for Severe Traumatic Brain Injury in Japan
Therapeutic Strategy for Severe Head Trauma Patients With Mild Hypothermia and Estimation of Medical Expenses in Japan
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- Yamaguchi University Hospital · Academic / Other
- Sex
- All
- Age
- 15 Years – 69 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to determine if mild hypothermia therapy, for severe head trauma patients, improves neurological outcome.
Detailed description
Mild hypothermia therapy shows protective effects for damaged brains of animals and post cardiac arrest patients. However, Clifton et al. reported that mild hypothermia has no protective effect for severe head trauma but has a risk of complications. In this study, all the participants must be treated with continuous monitoring of cardiac output and jugular venous oxygen saturation to get optimal physiological conditions. Adequate anesthesia such as neuroleptanesthesia is essential to maintain organ function and tissue microcirculation. Participants are randomly assigned to two groups of mild hypothermia (32.0 - 34.0 degree Celsius) and anti-hyperthermia (35.5 - 37.0 C). The body temperature must be kept for at least 72 hours. Hypothermia must be induced within 6 hours after traumatic brain injury. Glasgow outcome score at 6 months after injury and the total medical expenses of the two groups will be evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Therapeutic mild hypothermia | Keeping 32 - 34 degree celsius of core temperature at least for 72 hours. |
Timeline
- Start date
- 2002-12-01
- Primary completion
- 2008-09-01
- Completion
- 2008-09-01
- First posted
- 2005-08-24
- Last updated
- 2012-05-11
Locations
43 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00134472. Inclusion in this directory is not an endorsement.